Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Lin, Heng Hsu ^a   Lee, Jen Kuang ^a,b,c   Yang, Chung Yi ^d   Lien, Yu Chung ^b   Huang, Jenq Wen ^b   Wu, Cho Kai ^b,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diastolic dysfunction; Echocardiography; Epicardial fat; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FAT;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EPICARDIAL FAT; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAABDOMINAL FAT; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; PERICARDIUM; PERITONEAL DIALYSIS; TISSUE DOPPLER IMAGING;

ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERICARDIUM; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84883648097     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-127     Document Type: Article

References (42)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32:S112-S119. 10.1053/ajkd.1998.v32.pm9820470, 9820470.
2. Bajraktari G, Berbatovci-Ukimeraj M, Hajdari A, Ibraimi L, Daullxhiu I, Elezi Y, Ndrepepa G. Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction. Croat Med J 2009, 50:543-549. 10.3325/cmj.2009.50.543, 2802087, 20017222.
3. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 2006, 11:36-41.
4. Wu CK, Yang CY, Lin JW, Hsieh HJ, Chiu FC, Chen JJ, Lee JK, Huang SW, Li HY, Chiang FT, Tsai CT. The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling. Obesity (Silver Spring) 2012, 20:730-737.
5. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003, 16:85-94.
6. Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, Kremastinos DT. Association of left ventricular diastolic dysfunction with elevated nt-pro-bnp in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue doppler imaging parameters and nt-pro-bnp levels for adverse outcome. Shock 2010, 33:141-148. 10.1097/SHK.0b013e3181ad31f8, 19487972.
7. Fontan MP, Rodriguez-Carmona A, Cordido F, Garcia-Buela J. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. Am J Kidney Dis 1999, 34:824-831. 10.1016/S0272-6386(99)70038-7, 10561137.
8. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004, 43:1047-1055. 10.1053/j.ajkd.2004.02.017, 15168385.
9. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT. Nutritional status over time in hemodialysis and peritoneal dialysis. JASN 2001, 12:1272-1279.
10. Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, Kim JK, Hwang SD, Lee HK. Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int 2011, 31:67-73. 10.3747/pdi.2009.00131, 20448238.
11. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (vest). Circulation 2001, 103:2055-2059. 10.1161/01.CIR.103.16.2055, 11319194.
12. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009, 22:1311-1319. quiz 1417-1318, 10.1016/j.echo.2009.10.013, 19944955.
13. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466. 10.1161/01.CIR.0000099542.57313.C5, 14581396.
14. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006, 91:4620-4627. 10.1210/jc.2006-1044, 16895955.
15. Nakazato R, Dey D, Cheng VY, Gransar H, Slomka PJ, Hayes SW, Thomson LE, Friedman JD, Min JK, Berman DS. Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis 2012, 221:422-426. 10.1016/j.atherosclerosis.2011.12.018, 22305262.
16. Cavalcante JL, Tamarappoo BK, Hachamovitch R, Kwon DH, Alraies MC, Halliburton S, Schoenhagen P, Dey D, Berman DS, Marwick TH. Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol 2012, 110:1793-1798. 10.1016/j.amjcard.2012.07.045, 22980968.
17. Khawaja T, Greer C, Chokshi A, Chavarria N, Thadani S, Jones M, Schaefle K, Bhatia K, Collado JE, Shimbo D, Einstein AJ, Schulze PC. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 2011, 108:397-401. 10.1016/j.amjcard.2011.03.058, 21565323.
18. Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 2010 Feb, 10(1):46-53.
19. Wu CK, Lee JK, Chiang FT, Yang CH, Huang SW, Hwang JJ, Lin JL, Tseng CD, Chen JJ, Tsai CT. Plasma levels of tumor necrosis factor-alpha and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum ca2+ atpase. Crit Care Med 2011, 39:984-992. 10.1097/CCM.0b013e31820a91b9, 21263314.
20. Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, Hwang JJ, Lin JL, Tseng CD, Chiang FT. Genetic polymorphisms of the angiotensin ii type 1 receptor gene and diastolic heart failure. J Hypertens 2009, 27:502-507. 10.1097/HJH.0b013e32831fda3a, 19330904.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458. 10.1016/0002-9149(86)90771-X, 2936235.
22. Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C, Morricone L, Corsi MM, Sardanelli F, Iacobellis G. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010, 105:1831-1835. 10.1016/j.amjcard.2010.01.368, 20538139.
23. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A 1995, 92:4862-4866. 10.1073/pnas.92.11.4862, 41807, 7539136.
24. Fernstrom A, Hylander B, Moritz A, Jacobsson H, Rossner S. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998, 18:166-171.
25. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989, 94:225-232. 10.1016/0300-9629(89)90540-9, 2591189.
26. lacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543. 10.1038/ncpcardio0319, 16186852.
27. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011, 34(Suppl 2):S371-S379. 3632210, 21525485.
28. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009, 119:1661-1670. 10.1161/CIRCULATIONAHA.108.821181, 19289637.
29. Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 2008, 295:E313-E322. 10.1152/ajpendo.90296.2008, 2519760, 18492768.
30. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler Thromb Vasc Biol 2005, 25:2594-2599. 10.1161/01.ATV.0000188508.40052.35, 16195477.
31. Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009, 94:4472-4482. 10.1210/jc.2009-0436, 19820028.
32. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006, 91:4689-4695. 10.1210/jc.2006-0584, 16926257.
33. Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, Da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS, Kumar S, Pagano D, McTernan PG. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2009, 94:261-267.
34. Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J 2011, 52:139-142. 10.1536/ihj.52.139, 21646734.
35. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, Higashida M, Mikasa H, Nakaya Y, Takanashi S, Igarashi T, Kitagawa T, Sata M. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011, 58:248-255. 10.1016/j.jacc.2011.01.048, 21737014.
36. Atalar F, Gormez S, Caynak B, Akan G, Tanriverdi G, Bilgic-Gazioglu S, Gunay D, Duran C, Akpinar B, Ozbek U, Buyukdevrim AS, Yazici Z. The role of mediastinal adipose tissue 11beta-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease. Cardiovasc Diabetol 2012, 11:115. 10.1186/1475-2840-11-115, 3515420, 23009206.
37. Kim HM, Kim KJ, Lee HJ, Yu HT, Moon JH, Kang ES, Cha BS, Lee HC, Lee BW, Kim YJ. Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol 2012, 11:83. 10.1186/1475-2840-11-83, 3461492, 22809408.
38. Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, Fukuda D, Hirata Y, Kurobe H, Soeki T, Iwase T, Kusunose K, Niki T, Yamaguchi K, Taketani Y, Yagi S, Tomita N, Yamada H, Wakatsuki T, Harada M, Kitagawa T, Sata M. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in japanese subjects. Cardiovasc Diabetol 2012, 11:106. 10.1186/1475-2840-11-106, 3489699, 22963346.
39. van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Schar M, Bax JJ, Smit JW, Romijn JA, de Roos A, Lamb HJ. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 2008, 29:1516-1522. 10.1093/eurheartj/ehn207, 18492680.
40. Iacobellis G, Leonetti F, Singh N, Sharma AM. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol 2007, 115:272-273. 10.1016/j.ijcard.2006.04.016, 16759715.
41. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389. 10.1126/science.1631560, 1631560.
42. Lee JK, Lin HH, Tsai CT, Chen JJ, Kuo CC, Lien YC, Lin JW, Huang JW, Hwang SW, Hwang JJ, Tseng CD, Chiang FT, Wu CK. Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis 2012, 22:974-980. 10.1016/j.numecd.2011.01.001, 21592755.